Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone versus placebo for severe hospital pneumonia in ICU patients
RBR-9th6k46Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) comparing Hydrocortisone + standard treatment with Placebo + standard treatment (2 arms). Started Oct 2022; status: completed.
02
Drugs
hydrocortisone
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on RBR-9th6k46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9th6k46.